MedPath

The clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control

Not Applicable
Conditions
- Bronchial asthma with no treatment - Healthy non-smoker
Registration Number
JPRN-UMIN000010675
Lead Sponsor
Department of Pulmonary Medicine, Fukushima Medical University, School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with respiratory diseases other than asthma. 2. Pregnant women or breast feeding women 3. Patients who are unable to give informed consent. 4. Inappropriate patients judged by respiratory physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare diurnal variations and week-to-week variations of FeNO levels in asthmatic subjects before and after asthma treatment
Secondary Outcome Measures
NameTimeMethod
To compare whether there are diurnal and week-to-week variations of FeNO levels in asthmatic subjects when they are devided into controlled and uncontrolled state.
© Copyright 2025. All Rights Reserved by MedPath